Id | Content |
---|---|
F1 | These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. Genworks 2 owned such shares of common stock on September 20, 2018, the date on which the reporting person became a director of Ionis Pharmaceuticals, Inc. |